{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:20:03Z","timestamp":1787030403866,"version":"build-2736575974"},"reference-count":50,"publisher":"Baishideng Publishing Group Inc.","issue":"16","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2021,4,28]]},"DOI":"10.3748\/wjg.v27.i16.1728","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T23:11:58Z","timestamp":1618960318000},"page":"1728-1737","source":"Crossref","is-referenced-by-count":26,"title":["Hepatitis C virus micro-elimination: Where do we stand?"],"prefix":"10.3748","volume":"27","author":[{"given":"Alessandra","family":"Mangia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Cotugno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Cocomazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Maddalena","family":"Squillante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Piazzolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(16)30181-9"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.10.048"},{"key":"B3","unstructured":"AASLD.   Call to Action for Liver Associations to Advance Progress Towards Viral Hepatitis Elimination: A Focus on Simplified Approaches to HCV Testing and Cure. AASLD 2019. [cited 26 October 2020]. Available from: https:\/\/www.aasld.org\/"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.08.018"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14324"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(20)30238-7"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2020.07.042"},{"key":"B8","unstructured":"Lens S, Miralpeix A, Galvez M, Martro E, Gonzalez N, Rodriguez-Trajes S, Mari\u00f1o Z, Saludes V, Reyes-Ure\u00f1a J, Major X, Colom J, Forns X.   Impact of the lockdown in an externalized HCV linkage-to-care model focusing on PWID patients with ongoing high risk practices. The Liver Meeting Digital Experience AASLD. 13-16 November 2020. [cited 26 December 2020]. Available from: http:\/\/www.lingyuint.com\/2020\/2020_aasld.html"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit271"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.06.033"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1666841"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/liv.13186"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.11.004"},{"key":"B14","doi-asserted-by":"crossref","unstructured":"Olafsson S, Fridriksdottir RH, Tyrfingsson T, Runarsdottir V, Hansdottir I, Bergmann OM, Bj\u00f6rnsson ES, Johannsson B, Sigurdardottir B, L\u00f6ve A, Baldvinsdnottir GE, L\u00f6ve T J, Sigmundsdottir G, J\u00f3sefsd\u00f3ttir KS, Hernandez UB, Heimisdottir M, Gottfredsson M. Iceland may already have reached the WHO 2030 targets for diagnosis and treatment of hepatitis C virus infection. Results from the Treatment as Prevention for Hepatitis C (TrapHepC) program. J Hepatol  2019; 70: THU 412","DOI":"10.1016\/S0618-8278(19)30659-0"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm6541a2"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(19)30483-8"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/liv.14222"},{"key":"B18","unstructured":"PEAHC.   Plan Estrategico para el abordaje de la hepatitis C en el sistema nacional de salud 2020. [cited 26 October 2020]. Available from: http:\/\/www.msssi.goves\/ciudadanos\/enfLesiones\/enfTrasmisibles\/docs\/plan_estrategico_hepatitis_C.pdf"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgh-2020-003767"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)30462-8"},{"key":"B21","unstructured":"Mahmood H, Qureshi H, Glass N, Averhoff F.   Optimizing medicines and treatment regimens for hepatitis C patients in Pakistan. World Hepatitis Summit; November 1-3, 2017; Sao Paulo, Brazil, 2017: 4a. [cited 10 October 2020]. Available from: https:\/\/www.researchgate.net\/publication\/327361674_Optimizing_medicines_and_treatment_regimens_for_hepatitis_C_patients_in_Pakistan"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-019-1157-1"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-020-09152-z"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/jgh.12355"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/hep.26387"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(10)61053-7"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-018-6357-x"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.01.012"},{"key":"B29","doi-asserted-by":"crossref","unstructured":"Ustianowski A, White M, Bell S, Bennet J, Pavey K, O\u2019Connell L, Smiles J Hammond S, Horne M, Roberts D, Vilar FJ. Rapid test & treat program successfully facilitating hepatitis C micro-elimination in a women\u2019s prison. EASL  2020; SAT280","DOI":"10.1016\/S0168-8278(20)32033-X"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41395-018-0157-x"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/jvh.13240"},{"key":"B32","unstructured":"Wong A, Jimenez-Mutiloa E, Di Marco V, Perez F, Macedo G, Brixko C, Ranieri R, campanale F, Bascia A, Fernandez-Rodriguez CM, De Ledinghen V, Maida I, Mangia A, Barrett L, Teti E, Figueiredo LM, AmadoLEM, Retortillo MG, Borgia SM, Mertens M, Hernandez C, Ntalla I, Vanstraelen K, Rosati S. Value of SOF\/VEL as pangenotypic pan fibrotic HCV treatment in implementing a test and treat strategy in prisons: real-world care management from 6 countries. Hepatology 2020; 72: 944"},{"key":"B33","unstructured":"Llaneras J, Barreira-Diaz A, Uriona S, Rando A, Barciela MR, Velasquez F, Rodriguez-Frias F, Rodr\u00edguez\u2010Fr\u00edas F, Arranz M, Esteban-Mur R, Ferret MAB.  Hepatology 2020; 858 A hospital free of hepatitis C: hepatitis C virus screening program in an emergency department of a tertiary hospital of a high-income country. Hepatology 2020; 72: 858"},{"key":"B34","unstructured":"Caroli A, Franceschet I, Fasci-Spurio F. Girardi L, Cappuccio R, Checchin D, Lamboglia F, forti A, Scarparo C. Is hospital admission an ideal condition for HCV condition for HCV screening? EASL 2020; SAT278"},{"key":"B35","unstructured":"Wang SH, Brogden R. Automated viral Hepatitis (HCV and HBV) screening: lesson on expansion and sustainability amidst the COVID-19 pandemic. Hepatology 2020; 72: 947"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(17)30375-3"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(18)30304-2"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/add.13948"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.191"},{"key":"B40","unstructured":"Mangia A, Campanozzi F, Cotugno R, Canosa A, De Giorgi A, Piazzolla AV, Iannuzziello C, Augello N, Cocomazzi G, campanozzi F. Intensified screening, diagnosis and linkage to care program for SUD patients is associated with improvement in HCV care cascade. Hepatology 2020; 72: 970"},{"key":"B41","unstructured":"Addish E, Zellman H, Kuncio D, Kostman J, Viner K, Trooskin S. Microelimination among PWUD: outcomes of a patient navigation model vs an embebbed treatment mode. Hepatology 2020; 72: 657"},{"key":"B42","unstructured":"Boschini A, Piselli P, Smacchia C, Poletti R, Begnini M, Ottogalli P, Cimaglia C, Parracino MP, Girardi E. HCV treatment and reinfection risk in injecting drug users in residential treatment setting for drug addiction. San Patrignano HCV-free. Hepatology 2020; 72: 917"},{"key":"B43","unstructured":"Forns X, Colom J, Garcia-Retortillo M, Quer JC, Lens S, Dominguez-Hernandez R, Casado M.    Point of care hepatitis C testing and treating strategy in people who inject drugs in Harm reduction and addiction centers for hepatitis C elimination. The Liver Meeting Digital Experience AASLD. 13-16 November 2020. [cited 26 December 2020]. Available from: https:\/\/www.aasld.org\/event\/liver-meeting"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat1469"},{"key":"B45","unstructured":"Nallapeta NS, Jindal R, Edwards J, Martinez A. HCV micro-elimination: implementation of the internist-addiction medicine-hepatology colocalization (IAHC) model. INHSU 2019; 118"},{"key":"B46","unstructured":"Cotte L, Huleux T, Raffi F, Rey D, Delobel P, Gagneux-Brunon A, Jacomet C, Palich R, Laroche H, Cabi\u00e9 A, Hoen B, Chidiac C, Pradat P.   HCV incidence is still increasing in French HIV-infected MSM. 25th Conference on Retroviruses and Opportunistic Infections (CROI). 4-7 March 2018. Boston. Abstract 591"},{"key":"B47","unstructured":"Braun DL, Hampel BH, Nguyen H.   A treatment as prevention trial to eliminate HCV in HIV+MSM: the Swiss HCV free Trial. 25th Conference on Retroviruses and Opportunistic Infections (CROI). 4-7 March 2018. Boston. Abstract 81LB"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(20)30617-6"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1177\/2150132720969554"},{"key":"B50","unstructured":"IFRC.   Community-based health care, including outreach and campaigns, in the context of the COVID-19 pandemic. [cited 26 October 2020]. Available from: https:\/\/www.unicef.org\/media\/68811\/file\/Guidance-Community-based"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"link":[{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v27\/i16\/1728.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T23:14:43Z","timestamp":1618960483000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.wjgnet.com\/1007-9327\/full\/v27\/i16\/1728.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":50,"journal-issue":{"issue":"16"},"URL":"https:\/\/doi.org\/10.3748\/wjg.v27.i16.1728","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,28]]}}}